Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to Oric Pharmaceuticals (ORIC) yesterday and set a price target of $52.00.
The post Oppenheimer Issues a Buy Rating on Oric Pharmaceuticals (ORIC) appeared first on Smarter Analyst.
Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-issues-a-buy-rating-on-oric-pharmaceuticals-oric/

#SmarterAnalyst